Molina Healthcare Q4 EPS rises to $4.44; 2025 adjusted EPS guidance at least $24.50
Molina Healthcare reported fourth quarter 2024 GAAP earnings of $4.44 per diluted share, up from $3.70 a year earlier, and full year 2024 GAAP EPS of $20.42, up 9%. The company also issued full year 2025 guidance of at least $24.50 adjusted EPS and at least $22.50 GAAP EPS, with premium revenue of approximately $42 billion.
Key points
- Q4 2024 total revenue was $10,499 million, compared with $9,048 million in Q4 2023
- Full year 2024 GAAP EPS was $20.42 (up 9%) and adjusted EPS was $22.65 (up 8%)
- 2025 guidance includes approximately $1.00 per diluted share of implementation costs for recent Medicaid and Medicare Duals contract wins
- Operating cash flow for 2024 was $644 million, compared with $1,662 million in 2023
The filing
Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.